Article
Using Natural Product Inhibitors to Validate Hsp90 as a Molecular Target in Cancer
1 Jun 2006
Abstract excerpt
Heat shock protein 90 (Hsp90) is a molecular chaperone whose association is required for stability and function of multiple mutated, chimeric, and over-expressed signaling proteins that promote cancer cell growth and/or survival. Hsp90 client proteins include telomerase, mutated p53, Bcr-Abl, Raf-1, Akt, HER2/Neu (ErbB2), mutated B-Raf, mutated EGF receptor, and HIF-1alpha. Hsp90 inhibitors, by interacting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
